Search results

Magga 2019 Mol Ther
...Laitinen M, Pasternack A, Koch WJ, Alitalo K, Kivelä R, Ritvos O, Kerkelä R (2019) Systemic blockade of ACVR2B ligands protects myocardium from acute i ...aitinen M, Pasternack A, Koch WJ, Alitalo K, Kivelae R, Ritvos O, Kerkelae R

2 KB (358 words) - 11:46, 25 July 2019
Kivelae 2014 EMBO Mol Med
...JJ, Anisimov A, Mäyränpää MI, Lindeman JH, Eklund L, Hellberg S, Hlushchuk R, Zhuang ZW, Simons M, Djonov V, Knuuti J, Mervaala E, Alitalo K (2016) VEGF ...imov A, Maeyraenpaeae MI, Lindeman Jan HN, Eklund L, Hellberg S, Hlushchuk R, Zhuang ZW, Simons M, Djonov V, Knuuti J, Mervaala E, Alitalo K

2 KB (332 words) - 13:12, 4 July 2022
Raesaenen 2016 Proc Natl Acad Sci U S A
...alainen I, Kerkelä R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, Kivelä R, Alitalo K (2016) VEGF-B gene therapy inhibits doxorubicin-induced cardioto ...ainen I, Kerkelae R, Siltanen A, Backman JT, Mervaala E, Hulmi JJ, Kivelae R, Alitalo K

3 KB (365 words) - 12:05, 25 July 2019
Nissinen 2016 Sci Rep
...nen M, Poikonen AR, Koskinen S, Mervaala E, Pasternack A, Ritvos O, Kivelä R, Hulmi JJ (2016) Systemic blockade of ACVR2B ligands prevents chemotherapy- ...en M, Poikonen AR, Koskinen S, Mervaala E, Pasternack A, Ritvos O, Kivelae R, Hulmi JJ

2 KB (316 words) - 15:29, 13 November 2017